'Non-criteria' aPL tests

Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010

M. L. Bertolaccini, O. Amengual, T. Atsumi, W. L. Binder, B. De Laat, R. Forastiero, W. H. Kutteh, M. Lambert, H. Matsubayashi, Vijaya Murthy, M. Petri, J. H. Rand, M. Sanmarco, A. E. Tebo, S. S. Pierangeli

Research output: Contribution to journalArticle

88 Citations (Scopus)

Abstract

Current classification criteria for definite APS recommend the use of one or more of three positive standardized laboratory assays, including anticardiolipin antibodies (aCL), lupus anticoagulant (LA), and antibodies directed to β2glycoprotein I (anti-β2GPI) to detect antiphospholipid antibodies (aPL) in the presence of at least one of the two major clinical manifestations (i.e., thrombosis or pregnancy morbidity) of the syndrome. Several other autoantibodies shown to be directed to phospholipids and/or their complexes with phospholipids and/or to proteins of the coagulation cascade, as well as a mechanistic test for resistance to annexin A5 anticoagulant activity, have been proposed to be relevant to APS. A task force of worldwide scientists in the field discussed and analyzed critical questions related to 'non-criteria' aPL tests in an evidence-based manner during the 13th International Congress on Antiphospholipid Antibodies (APLA 2010, 13-16 April 2010, Galveston, Texas, USA). This report summarizes the findings, conclusions, and recommendations of this task force.

Original languageEnglish (US)
Pages (from-to)191-205
Number of pages15
JournalLupus
Volume20
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Antiphospholipid Antibodies
Advisory Committees
Education
Phospholipids
Lupus Coagulation Inhibitor
Anticardiolipin Antibodies
Annexin A5
Autoantibodies
Anticoagulants
Thrombosis
Morbidity
Pregnancy
Antibodies
Proteins

Keywords

  • autoantibodies
  • IgA
  • phosphatidylethanolamine
  • prothrombin

ASJC Scopus subject areas

  • Rheumatology

Cite this

'Non-criteria' aPL tests : Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. / Bertolaccini, M. L.; Amengual, O.; Atsumi, T.; Binder, W. L.; De Laat, B.; Forastiero, R.; Kutteh, W. H.; Lambert, M.; Matsubayashi, H.; Murthy, Vijaya; Petri, M.; Rand, J. H.; Sanmarco, M.; Tebo, A. E.; Pierangeli, S. S.

In: Lupus, Vol. 20, No. 2, 02.2011, p. 191-205.

Research output: Contribution to journalArticle

Bertolaccini, ML, Amengual, O, Atsumi, T, Binder, WL, De Laat, B, Forastiero, R, Kutteh, WH, Lambert, M, Matsubayashi, H, Murthy, V, Petri, M, Rand, JH, Sanmarco, M, Tebo, AE & Pierangeli, SS 2011, ''Non-criteria' aPL tests: Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010', Lupus, vol. 20, no. 2, pp. 191-205. https://doi.org/10.1177/0961203310397082
Bertolaccini, M. L. ; Amengual, O. ; Atsumi, T. ; Binder, W. L. ; De Laat, B. ; Forastiero, R. ; Kutteh, W. H. ; Lambert, M. ; Matsubayashi, H. ; Murthy, Vijaya ; Petri, M. ; Rand, J. H. ; Sanmarco, M. ; Tebo, A. E. ; Pierangeli, S. S. / 'Non-criteria' aPL tests : Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010. In: Lupus. 2011 ; Vol. 20, No. 2. pp. 191-205.
@article{e48fc34ec54c42daac59d1237870569d,
title = "'Non-criteria' aPL tests: Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010",
abstract = "Current classification criteria for definite APS recommend the use of one or more of three positive standardized laboratory assays, including anticardiolipin antibodies (aCL), lupus anticoagulant (LA), and antibodies directed to β2glycoprotein I (anti-β2GPI) to detect antiphospholipid antibodies (aPL) in the presence of at least one of the two major clinical manifestations (i.e., thrombosis or pregnancy morbidity) of the syndrome. Several other autoantibodies shown to be directed to phospholipids and/or their complexes with phospholipids and/or to proteins of the coagulation cascade, as well as a mechanistic test for resistance to annexin A5 anticoagulant activity, have been proposed to be relevant to APS. A task force of worldwide scientists in the field discussed and analyzed critical questions related to 'non-criteria' aPL tests in an evidence-based manner during the 13th International Congress on Antiphospholipid Antibodies (APLA 2010, 13-16 April 2010, Galveston, Texas, USA). This report summarizes the findings, conclusions, and recommendations of this task force.",
keywords = "autoantibodies, IgA, phosphatidylethanolamine, prothrombin",
author = "Bertolaccini, {M. L.} and O. Amengual and T. Atsumi and Binder, {W. L.} and {De Laat}, B. and R. Forastiero and Kutteh, {W. H.} and M. Lambert and H. Matsubayashi and Vijaya Murthy and M. Petri and Rand, {J. H.} and M. Sanmarco and Tebo, {A. E.} and Pierangeli, {S. S.}",
year = "2011",
month = "2",
doi = "10.1177/0961203310397082",
language = "English (US)",
volume = "20",
pages = "191--205",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - 'Non-criteria' aPL tests

T2 - Report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010

AU - Bertolaccini, M. L.

AU - Amengual, O.

AU - Atsumi, T.

AU - Binder, W. L.

AU - De Laat, B.

AU - Forastiero, R.

AU - Kutteh, W. H.

AU - Lambert, M.

AU - Matsubayashi, H.

AU - Murthy, Vijaya

AU - Petri, M.

AU - Rand, J. H.

AU - Sanmarco, M.

AU - Tebo, A. E.

AU - Pierangeli, S. S.

PY - 2011/2

Y1 - 2011/2

N2 - Current classification criteria for definite APS recommend the use of one or more of three positive standardized laboratory assays, including anticardiolipin antibodies (aCL), lupus anticoagulant (LA), and antibodies directed to β2glycoprotein I (anti-β2GPI) to detect antiphospholipid antibodies (aPL) in the presence of at least one of the two major clinical manifestations (i.e., thrombosis or pregnancy morbidity) of the syndrome. Several other autoantibodies shown to be directed to phospholipids and/or their complexes with phospholipids and/or to proteins of the coagulation cascade, as well as a mechanistic test for resistance to annexin A5 anticoagulant activity, have been proposed to be relevant to APS. A task force of worldwide scientists in the field discussed and analyzed critical questions related to 'non-criteria' aPL tests in an evidence-based manner during the 13th International Congress on Antiphospholipid Antibodies (APLA 2010, 13-16 April 2010, Galveston, Texas, USA). This report summarizes the findings, conclusions, and recommendations of this task force.

AB - Current classification criteria for definite APS recommend the use of one or more of three positive standardized laboratory assays, including anticardiolipin antibodies (aCL), lupus anticoagulant (LA), and antibodies directed to β2glycoprotein I (anti-β2GPI) to detect antiphospholipid antibodies (aPL) in the presence of at least one of the two major clinical manifestations (i.e., thrombosis or pregnancy morbidity) of the syndrome. Several other autoantibodies shown to be directed to phospholipids and/or their complexes with phospholipids and/or to proteins of the coagulation cascade, as well as a mechanistic test for resistance to annexin A5 anticoagulant activity, have been proposed to be relevant to APS. A task force of worldwide scientists in the field discussed and analyzed critical questions related to 'non-criteria' aPL tests in an evidence-based manner during the 13th International Congress on Antiphospholipid Antibodies (APLA 2010, 13-16 April 2010, Galveston, Texas, USA). This report summarizes the findings, conclusions, and recommendations of this task force.

KW - autoantibodies

KW - IgA

KW - phosphatidylethanolamine

KW - prothrombin

UR - http://www.scopus.com/inward/record.url?scp=79953309701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953309701&partnerID=8YFLogxK

U2 - 10.1177/0961203310397082

DO - 10.1177/0961203310397082

M3 - Article

VL - 20

SP - 191

EP - 205

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 2

ER -